in\u00adflam\u00adma\u00adtion<\/a> space, Gilead is tack\u00adling chron\u00adic dis\u00adeases that cause life\u00adlong pain and dis\u00adabil\u00adi\u00adty, dras\u00adti\u00adcal\u00adly im\u00adpact\u00ading qual\u00adi\u00adty of life for mil\u00adlions of pa\u00adtients world\u00adwide. The com\u00adpa\u00adny\u2019s re\u00adsearch fo\u00adcus\u00ades on de\u00advel\u00adop\u00ading nov\u00adel ther\u00ada\u00adpies that tar\u00adget un\u00adder\u00adly\u00ading dis\u00adease mech\u00ada\u00adnisms rather than sim\u00adply man\u00adag\u00ading symp\u00adtoms, of\u00adfer\u00ading the po\u00adten\u00adtial for dis\u00adease mod\u00adi\u00adfi\u00adca\u00adtion and im\u00adproved long-term out\u00adcomes.\n<\/p>\nThese di\u00adverse pro\u00adgrams re\u00adflect a dis\u00adci\u00adplined, in\u00adno\u00adva\u00adtion-dri\u00adven strat\u00ade\u00adgy, one that care\u00adful\u00adly bal\u00adances sci\u00aden\u00adtif\u00adic am\u00adbi\u00adtion with a laser fo\u00adcus on de\u00adliv\u00ader\u00ading mean\u00ading\u00adful pa\u00adtient out\u00adcomes and ad\u00address\u00ading sig\u00adnif\u00adi\u00adcant un\u00admet med\u00adical needs.\n<\/p>\n
Ac\u00adcess with\u00adout lim\u00adits: Part\u00adner\u00adships that mat\u00adter<\/p>\n
Sci\u00aden\u00adtif\u00adic in\u00adno\u00adva\u00adtion alone can\u00adnot ad\u00address glob\u00adal health chal\u00adlenges with\u00adout de\u00adlib\u00ader\u00adate, sys\u00adtem-lev\u00adel ac\u00adcess plan\u00adning. Gilead has long em\u00adbed\u00added ac\u00adcess con\u00adsid\u00ader\u00ada\u00adtions across its port\u00adfo\u00adlio, work\u00ading to en\u00adsure that ad\u00advances in vi\u00adrol\u00ado\u00adgy, on\u00adcol\u00ado\u00adgy, and in\u00adflam\u00adma\u00adto\u00adry dis\u00adeases can reach pa\u00adtients in di\u00adverse health\u00adcare set\u00adtings around the world. This ap\u00adproach re\u00adflects a be\u00adlief that ac\u00adcess must be de\u00adsigned along\u00adside in\u00adno\u00adva\u00adtion, tak\u00ading in\u00adto ac\u00adcount af\u00adford\u00adabil\u00adi\u00adty, in\u00adfra\u00adstruc\u00adture, reg\u00adu\u00adla\u00adto\u00adry path\u00adways, and health\u00adcare ca\u00adpac\u00adi\u00adty.\n<\/p>\n
One re\u00adcent ex\u00adam\u00adple of this ap\u00adproach is Gilead\u2019s work to ex\u00adpand ac\u00adcess to its long-act\u00ading HIV pre\u00adven\u00adtion med\u00adica\u00adtion. In 2024, the com\u00adpa\u00adny signed roy\u00adal\u00adty-free vol\u00adun\u00adtary li\u00adcens\u00ades with six gener\u00adic man\u00adu\u00adfac\u00adtur\u00aders to make and sell the first twice year\u00adly treat\u00adment for HIV pre\u00adven\u00adtion in 120 low- and low\u00ader-mid\u00addle-in\u00adcome coun\u00adtries. Gilead al\u00adso com\u00adplet\u00aded ear\u00adly tech\u00adnol\u00ado\u00adgy trans\u00adfers to sup\u00adport man\u00adu\u00adfac\u00adtur\u00ading readi\u00adness, rec\u00adog\u00adniz\u00ading that time\u00adly ac\u00adcess re\u00adquires prepa\u00adra\u00adtion well in ad\u00advance of reg\u00adu\u00adla\u00adto\u00adry re\u00adview and lo\u00adcal ap\u00adprovals.\n<\/p>\n
Build\u00ading on its broad\u00ader ac\u00adcess frame\u00adwork, Gilead part\u00adners with glob\u00adal health or\u00adga\u00adni\u00adza\u00adtions, gov\u00adern\u00adments, and non-prof\u00adits to sup\u00adport ac\u00adcess across its port\u00adfo\u00adlio. This in\u00adcludes col\u00adlab\u00ado\u00adra\u00adtions with ini\u00adtia\u00adtives such as the U.S. State De\u00adpart\u00adment\u2019s PEP\u00adFAR pro\u00adgram and the Glob\u00adal Fund, which bring to\u00adgeth\u00ader com\u00adple\u00admen\u00adtary ex\u00adper\u00adtise in pro\u00adcure\u00adment, health sys\u00adtem sup\u00adport, and de\u00adliv\u00adery. These part\u00adner\u00adships are de\u00adsigned to help en\u00adsure that sci\u00aden\u00adtif\u00adic ad\u00advances across dis\u00adease ar\u00adeas can trans\u00adlate in\u00adto re\u00adal-world im\u00adpact.\n<\/p>\n
Through strate\u00adgic health\u00adcare in\u00adsti\u00adtu\u00adtion part\u00adner\u00adships world\u00adwide, Gilead helps de\u00advel\u00adop com\u00adpre\u00adhen\u00adsive screen\u00ading, test\u00ading and di\u00adag\u00adnos\u00adtic pro\u00adto\u00adcols for crit\u00adi\u00adcal vi\u00adral dis\u00adeases. These col\u00adlab\u00ado\u00adra\u00adtions ex\u00adtend be\u00adyond drug dis\u00adtri\u00adb\u00adu\u00adtion, en\u00adcom\u00adpass\u00ading ca\u00adpac\u00adi\u00adty build\u00ading, health\u00adcare work\u00ader train\u00ading and sup\u00adport for in\u00adfra\u00adstruc\u00adture de\u00advel\u00adop\u00adment. By strength\u00aden\u00ading health\u00adcare sys\u00adtems, these part\u00adner\u00adships aim to help en\u00adsure that break\u00adthrough ther\u00ada\u00adpies can be ef\u00adfec\u00adtive\u00adly de\u00adliv\u00adered to un\u00adder\u00adserved pop\u00adu\u00adla\u00adtions, trans\u00adlat\u00ading in\u00adno\u00adva\u00adtion in\u00adto re\u00adal-world im\u00adpact.\n<\/p>\n
This com\u00adpre\u00adhen\u00adsive ap\u00adproach re\u00adflects a broad\u00ader phi\u00adlos\u00ado\u00adphy deeply em\u00adbed\u00added in Gilead\u2019s cor\u00adpo\u00adrate cul\u00adture: health\u00adcare in\u00adno\u00adva\u00adtion must be in\u00adclu\u00adsive, sus\u00adtain\u00adable and glob\u00adal\u00adly rel\u00ade\u00advant to tru\u00adly trans\u00adform pa\u00adtient out\u00adcomes.\n<\/p>\n
2030 and be\u00adyond: A bold blue\u00adprint for trans\u00adfor\u00adma\u00adtive ther\u00ada\u00adpies<\/p>\n
Look\u00ading ahead, Gilead\u2019s strat\u00ade\u00adgy is to con\u00adtin\u00adue ac\u00adcel\u00ader\u00adat\u00ading in\u00adno\u00adva\u00adtion while main\u00adtain\u00ading dis\u00adci\u00adplined growth and re\u00adsource al\u00adlo\u00adca\u00adtion. By fo\u00adcus\u00ading on trans\u00adfor\u00adma\u00adtive ther\u00ada\u00adpies, strength\u00aden\u00ading strate\u00adgic health\u00adcare ecosys\u00adtem col\u00adlab\u00ado\u00adra\u00adtions, and dri\u00adving sus\u00adtain\u00adable stake\u00adhold\u00ader val\u00adue, Gilead aims to help shape the next era of bio\u00adphar\u00adma\u00adceu\u00adti\u00adcal in\u00adno\u00adva\u00adtion.<\/p>\n","protected":false},"excerpt":{"rendered":"In an era of rapid sci\u00aden\u00adtif\u00adic ad\u00advance\u00adment and on\u00adgo\u00ading glob\u00adal health chal\u00adlenges, Gilead Sci\u00adences is ad\u00advanc\u00ading a long-term…\n","protected":false},"author":2,"featured_media":368547,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[43],"tags":[102,2960,56,54,55],"class_list":["post-368546","post","type-post","status-publish","format-standard","has-post-thumbnail","category-healthcare","tag-health","tag-healthcare","tag-uk","tag-united-kingdom","tag-unitedkingdom"],"_links":{"self":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/368546","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/comments?post=368546"}],"version-history":[{"count":0,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/posts\/368546\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media\/368547"}],"wp:attachment":[{"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/media?parent=368546"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/categories?post=368546"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.newsbeep.com\/uk\/wp-json\/wp\/v2\/tags?post=368546"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}